MktsMarkets

DiaMedica Therapeutics Inc.
NASDAQ: DMACKey statistics
DMAC News
Stories mentioning DMAC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 7,987 | 6,699 | 6,437 | 5,822 | 5,656 | 6,470 | 4,983 | 3,928 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (10,482) | (9,213) | (9,033) | (8,007) | (8,144) | (8,419) | (6,883) | (5,638) |
| Interest Income | 470.00 | 472.00 | 440.00 | 313.00 | 444.00 | 543.00 | 618.00 | 524.00 |
| Interest Expense | ||||||||
| Other Expense | 447.00 | 1,236 | (21.00) | 1.00 | 443.00 | 1,670 | (2.00) | 2.00 |
| Pretax Income | (10,035) | (8,730) | (8,614) | (7,693) | (7,701) | (7,891) | (6,267) | (5,112) |
| Tax Provision | 7.00 | 10.00 | 6.00 | 6.00 | 6.00 | 9.00 | 7.00 | 7.00 |
| Net Income (Loss) | (10,042) | (8,740) | (8,620) | (7,699) | (7,707) | (7,900) | (6,274) | (5,119) |
| Earnings Per Share (Basic) | (0.19) | (0.19) | (0.17) | (0.18) | (0.18) | (0.20) | (0.15) | (0.13) |
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | 53,793 | 46,981 | 49,630 | 42,958 | 42,844 | 40,405 | 42,752 | 38,068 |
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DMAC
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is a stock listed on the Nasdaq Stock Market under the ticker symbol DMAC. It last traded at $8.79 (Nov 13, 2026, 4:00 PM ET), down 5.8% on the day. That gives DiaMedica Therapeutics a market capitalisation of $474.0M.
Over the past 52 weeks DMAC has traded between $5.25 and $11.00.
For the quarter ended Mar 31, 2026 it reported a net loss of $10.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$10.0M |
| Dec 31, 2025 | — | -$8.7M |
| Sep 30, 2025 | — | -$8.6M |
| Jun 30, 2025 | — | -$7.7M |
From DiaMedica Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…